By 2000 their share of the market had more than doubled to over 75%. On top of that, by 2001, sales of expensive patented medications made up nearly two-thirds of total drug sales.
En 2000, cette proportion avait plus que doublé, passant à plus de 75 p. 100. De plus, en 2001, les ventes de produits brevetés coûteux formaient près des deux tiers des ventes totales de médicaments.